Patient Background:

Mrs. L is a 79-year-old woman with moderate Alzheimer disease living at home with her daughter. Over the past three months, she has developed escalating irritability, pacing, verbal outbursts, and resistance to care. Sleep is fragmented, and caregivers report increased emotional burden. There has been no recent medication change.

Family history is negative for neuropsychiatric disorders. Her daughter…read more

1. Please provide a minimum of a 3 sentence response.
2. 1.What thresholds prompt pharmacologic treatment in persistent moderate-to-severe agitation?
3. 2.How do you prioritize mechanism when agitation reflects mixed symptoms?

Show Less

Patient Medical History: An 81-year-old former attorney with a 6-year history of Alzheimer disease presents with progressive behavioral disturbance. Comorbidities include controlled hypertension and osteoarthritis. No prior psychiatric history. Current medications include a cholinesterase inhibitor and antihypertensive therapy. No recent medication changes.

Family History: Mother developed late-onset dementia. No family history of primary psychotic or bipolar disorders.

Presentation: Over 4 months, he has developed pacing, verbal aggression, resistance to bathing, and accusatory delusions that caregivers are stealing. Agitation worsens in the late afternoon. Two episodes of physical aggression toward his spouse have occurred without injury. His wife reports fragmented sleep, escalating emotional strain, and concern about potential institutionalization.

Clinical Findings: MMSE 14/30 with impaired executive function and recall. Affect irritable with intermittent suspiciousness. No visual hallucinations. No focal neurologic deficits or parkinsonism. Pain assessment reveals no contributory findings.

Laboratory Findings: CBC, CMP, thyroid function, vitamin B12, and urinalysis are normal. No evidence of infection or metabolic disturbance. MRI from the prior year showed diffuse cortical atrophy consistent with Alzheimer disease.

Agitation in Alzheimer disease frequently clusters with irritability, disinhibition, and psychotic features and is associated with accelerated cognitive and functional decline, heightened caregiver burden, and increased risk of institutionalization. Proposed mechanisms include disruption of frontal–subcortical circuits and impaired serotonergic, dopaminergic, and noradrenergic modulation affecting impulse control and threat perception.

Show Less